ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Cryopreservation impairs engraftment in bone marrow transplantation (2022)
Costa, Thalita Cristina de Mello ; Donadel, Camila Derminio; Siqueira, Thais Helena R.; André, Nathália Cristine; Darrigo Júnior, Luiz Guilherme ; Pieroni, Fabiano; Dias, Juliana Bernardes Elias; Stracieri, Ana Beatriz Pereira Lima; Grecco, Carlos Eduardo Setanni; Faria, Joana Teresa Bisinella de ; Vieira, Ana Carolina de Jesus; Mesquita, Camila Campos; Silva, Bruno Garcia Peixoto Pires da; Laurindo, Patrícia da Silva; Valeri, Pedro Augusto de Oliveira; Moraes, Daniela Aparecida de; Ventura, Gabriela; Oliveira, Maria Carolina; Guerino-Cunha, Renato Luiz ; De Santis, Gil Cunha
Source: Blood. Conference titles: ASH Annual Meeting Abstracts. Unidade: FMRP
Subjects: CRIOPRESERVAÇÃO, TRANSPLANTE DE MEDULA ÓSSEA, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Thalita Cristina de Mello et al. Cryopreservation impairs engraftment in bone marrow transplantation. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2022-165539. Acesso em: 25 jan. 2026. , 2022
APA
Costa, T. C. de M., Donadel, C. D., Siqueira, T. H. R., André, N. C., Darrigo Júnior, L. G., Pieroni, F., et al. (2022). Cryopreservation impairs engraftment in bone marrow transplantation. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2022-165539
NLM
Costa TC de M, Donadel CD, Siqueira THR, André NC, Darrigo Júnior LG, Pieroni F, Dias JBE, Stracieri ABPL, Grecco CES, Faria JTB de, Vieira AC de J, Mesquita CC, Silva BGPP da, Laurindo P da S, Valeri PA de O, Moraes DA de, Ventura G, Oliveira MC, Guerino-Cunha RL, De Santis GC. Cryopreservation impairs engraftment in bone marrow transplantation [Internet]. Blood. 2022 ; 140 12852-12853.[citado 2026 jan. 25 ] Available from: https://doi.org/10.1182/blood-2022-165539
Vancouver
Costa TC de M, Donadel CD, Siqueira THR, André NC, Darrigo Júnior LG, Pieroni F, Dias JBE, Stracieri ABPL, Grecco CES, Faria JTB de, Vieira AC de J, Mesquita CC, Silva BGPP da, Laurindo P da S, Valeri PA de O, Moraes DA de, Ventura G, Oliveira MC, Guerino-Cunha RL, De Santis GC. Cryopreservation impairs engraftment in bone marrow transplantation [Internet]. Blood. 2022 ; 140 12852-12853.[citado 2026 jan. 25 ] Available from: https://doi.org/10.1182/blood-2022-165539
Trabalho de evento-resumo periodico
Real-world data on the occurrence of vaso-occlusive crises (VOCs) in patients with sickle cell disease (SCD) and a high baseline disease burden treated with crizanlizumab: results from a managed access program (MAP) (2021)
Cançado, Rodolfo D.; Colombatti, Raffaella; Quarta, Antonella; Arcioni, Francesco; DeBonnett, Laurie; Soliman, Wesam; Sarkar, Rajendra; Pinto, Ana Cristina Silva
Source: Blood. Conference titles: ASH Annual Meeting Abstracts. Unidade: FMRP
Assunto: ANEMIA FALCIFORME
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CANÇADO, Rodolfo D. et al. Real-world data on the occurrence of vaso-occlusive crises (VOCs) in patients with sickle cell disease (SCD) and a high baseline disease burden treated with crizanlizumab: results from a managed access program (MAP). Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-152407. Acesso em: 25 jan. 2026. , 2021
APA
Cançado, R. D., Colombatti, R., Quarta, A., Arcioni, F., DeBonnett, L., Soliman, W., et al. (2021). Real-world data on the occurrence of vaso-occlusive crises (VOCs) in patients with sickle cell disease (SCD) and a high baseline disease burden treated with crizanlizumab: results from a managed access program (MAP). Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2021-152407
NLM
Cançado RD, Colombatti R, Quarta A, Arcioni F, DeBonnett L, Soliman W, Sarkar R, Pinto ACS. Real-world data on the occurrence of vaso-occlusive crises (VOCs) in patients with sickle cell disease (SCD) and a high baseline disease burden treated with crizanlizumab: results from a managed access program (MAP) [Internet]. Blood. 2021 ; 138 4180-4182.[citado 2026 jan. 25 ] Available from: https://doi.org/10.1182/blood-2021-152407
Vancouver
Cançado RD, Colombatti R, Quarta A, Arcioni F, DeBonnett L, Soliman W, Sarkar R, Pinto ACS. Real-world data on the occurrence of vaso-occlusive crises (VOCs) in patients with sickle cell disease (SCD) and a high baseline disease burden treated with crizanlizumab: results from a managed access program (MAP) [Internet]. Blood. 2021 ; 138 4180-4182.[citado 2026 jan. 25 ] Available from: https://doi.org/10.1182/blood-2021-152407
Trabalho de evento-resumo periodico
Efficacy and safety of eltrombopag combined with cyclosporine as first-line therapy in adults with severe acquired aplastic anemia: results of the interventional phase 2 single-arm soar study (2021)
Vallejo, Carlos; Jang, Jun Ho; Finelli, Carlo; Montaño Figueroa, Efreen; Norasetthada, Lalita; Calado, Rodrigo Tocantins ; Turgut, Mehmet; Peffault de Latour, Regis; Kriemler-Krahn, Ulrike; Haenig, Jens; Maier, Joan; Scheinberg, Phillip
Source: Blood. Conference titles: ASH Annual Meeting Abstracts. Unidade: FMRP
Subjects: CICLOSPORINAS, ANEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALLEJO, Carlos et al. Efficacy and safety of eltrombopag combined with cyclosporine as first-line therapy in adults with severe acquired aplastic anemia: results of the interventional phase 2 single-arm soar study. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-147733. Acesso em: 25 jan. 2026. , 2021
APA
Vallejo, C., Jang, J. H., Finelli, C., Montaño Figueroa, E., Norasetthada, L., Calado, R. T., et al. (2021). Efficacy and safety of eltrombopag combined with cyclosporine as first-line therapy in adults with severe acquired aplastic anemia: results of the interventional phase 2 single-arm soar study. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2021-147733
NLM
Vallejo C, Jang JH, Finelli C, Montaño Figueroa E, Norasetthada L, Calado RT, Turgut M, Peffault de Latour R, Kriemler-Krahn U, Haenig J, Maier J, Scheinberg P. Efficacy and safety of eltrombopag combined with cyclosporine as first-line therapy in adults with severe acquired aplastic anemia: results of the interventional phase 2 single-arm soar study [Internet]. Blood. 2021 ; 138 2174-2175.[citado 2026 jan. 25 ] Available from: https://doi.org/10.1182/blood-2021-147733
Vancouver
Vallejo C, Jang JH, Finelli C, Montaño Figueroa E, Norasetthada L, Calado RT, Turgut M, Peffault de Latour R, Kriemler-Krahn U, Haenig J, Maier J, Scheinberg P. Efficacy and safety of eltrombopag combined with cyclosporine as first-line therapy in adults with severe acquired aplastic anemia: results of the interventional phase 2 single-arm soar study [Internet]. Blood. 2021 ; 138 2174-2175.[citado 2026 jan. 25 ] Available from: https://doi.org/10.1182/blood-2021-147733
Trabalho de evento-resumo periodico
Clinical Signicance of Mitochondrial DNA Content in Acute Promyelocytic Leukemi (2021)
Araujo, Antônio Roberto Lucena de ; Martins, Diego Antonio Pereira ; Silva, Juan Luiz Coelho da ; Weinhäuser, Isabel ; Franca-Neto, Pedro Luis; Silveira, Douglas R. A.; Lima, Marinus M.; Schuringa, Jan Jacob ; Koury, Luisa C.; Melo, Raul Antonio Morais; Bittencourt, Rosane; Pagnano, Katia B.; Nunes, Elenaide C.; Fagundes, Evandro Maranhão ; Kerbauy, Fabio R.; Pontes, Lorena Lôbo Figueiredo ; Rego, Eduardo Magalhães
Source: Blood. Conference titles: ASH Annual Meeting Abstracts. Unidades: FMRP, FM
Subjects: DNA MITOCONDRIAL, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAUJO, Antônio Roberto Lucena de et al. Clinical Signicance of Mitochondrial DNA Content in Acute Promyelocytic Leukemi. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-151265. Acesso em: 25 jan. 2026. , 2021
APA
Araujo, A. R. L. de, Martins, D. A. P., Silva, J. L. C. da, Weinhäuser, I., Franca-Neto, P. L., Silveira, D. R. A., et al. (2021). Clinical Signicance of Mitochondrial DNA Content in Acute Promyelocytic Leukemi. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2021-151265
NLM
Araujo ARL de, Martins DAP, Silva JLC da, Weinhäuser I, Franca-Neto PL, Silveira DRA, Lima MM, Schuringa JJ, Koury LC, Melo RAM, Bittencourt R, Pagnano KB, Nunes EC, Fagundes EM, Kerbauy FR, Pontes LLF, Rego EM. Clinical Signicance of Mitochondrial DNA Content in Acute Promyelocytic Leukemi [Internet]. Blood. 2021 ; 138 3474-3475.[citado 2026 jan. 25 ] Available from: https://doi.org/10.1182/blood-2021-151265
Vancouver
Araujo ARL de, Martins DAP, Silva JLC da, Weinhäuser I, Franca-Neto PL, Silveira DRA, Lima MM, Schuringa JJ, Koury LC, Melo RAM, Bittencourt R, Pagnano KB, Nunes EC, Fagundes EM, Kerbauy FR, Pontes LLF, Rego EM. Clinical Signicance of Mitochondrial DNA Content in Acute Promyelocytic Leukemi [Internet]. Blood. 2021 ; 138 3474-3475.[citado 2026 jan. 25 ] Available from: https://doi.org/10.1182/blood-2021-151265
Trabalho de evento-resumo periodico
U2AF1 and other splicing factor gene mutations in telomere biology disorders are associated with hematologic neoplasia and worse overall survival (2021)
Groarke, Emma M.; Gutierrez-Rodrigues, Fernanda ; Ma, Xiaoyang; Patel, Bhavisha A.; Spitofsky, Nina; Browne, Paul V.; Chien, Kelly S.; Wu, Colin O.; DiNardo, Courtney D.; Colla, Simona; Calado, Rodrigo Tocantins ; Young, Neal S.
Source: Blood. Conference titles: ASH Annual Meeting Abstracts. Unidade: FMRP
Subjects: MUTAÇÃO GENÉTICA, NEOPLASIAS, SANGUE, TELÔMERO, MEDULA ÓSSEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GROARKE, Emma M. et al. U2AF1 and other splicing factor gene mutations in telomere biology disorders are associated with hematologic neoplasia and worse overall survival. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-146946. Acesso em: 25 jan. 2026. , 2021
APA
Groarke, E. M., Gutierrez-Rodrigues, F., Ma, X., Patel, B. A., Spitofsky, N., Browne, P. V., et al. (2021). U2AF1 and other splicing factor gene mutations in telomere biology disorders are associated with hematologic neoplasia and worse overall survival. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2021-146946
NLM
Groarke EM, Gutierrez-Rodrigues F, Ma X, Patel BA, Spitofsky N, Browne PV, Chien KS, Wu CO, DiNardo CD, Colla S, Calado RT, Young NS. U2AF1 and other splicing factor gene mutations in telomere biology disorders are associated with hematologic neoplasia and worse overall survival [Internet]. Blood. 2021 ; 138 862-864.[citado 2026 jan. 25 ] Available from: https://doi.org/10.1182/blood-2021-146946
Vancouver
Groarke EM, Gutierrez-Rodrigues F, Ma X, Patel BA, Spitofsky N, Browne PV, Chien KS, Wu CO, DiNardo CD, Colla S, Calado RT, Young NS. U2AF1 and other splicing factor gene mutations in telomere biology disorders are associated with hematologic neoplasia and worse overall survival [Internet]. Blood. 2021 ; 138 862-864.[citado 2026 jan. 25 ] Available from: https://doi.org/10.1182/blood-2021-146946
Trabalho de evento-resumo periodico
AGILE: a global, randomized, double-blind, phase 3 study of ivosidenib + azacitidine versus placebo + azacitidine in patients with newly diagnosed acute myeloid leukemia with an IDH1 mutation (2021)
Montesinos, Pau; Recher, Christian; Vives, Susana; Zarzycka, Ewa; Wang, Jianxiang; Bertani, Giambattista; Heuser, Michael; Calado, Rodrigo Tocantins ; Schuh, Andre C.; Yeh, Su-Peng; Daigle, Scott R.; Hui, Jianan; Zhang, Vickie; Pandya, Shuchi S.; Gianolio, Diego; Botton, Stephane de; Döhner, Hartmut
Source: Blood. Conference titles: ASH Annual Meeting Abstracts. Unidade: FMRP
Subjects: LEUCEMIA MIELOIDE, MUTAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONTESINOS, Pau et al. AGILE: a global, randomized, double-blind, phase 3 study of ivosidenib + azacitidine versus placebo + azacitidine in patients with newly diagnosed acute myeloid leukemia with an IDH1 mutation. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-147805. Acesso em: 25 jan. 2026. , 2021
APA
Montesinos, P., Recher, C., Vives, S., Zarzycka, E., Wang, J., Bertani, G., et al. (2021). AGILE: a global, randomized, double-blind, phase 3 study of ivosidenib + azacitidine versus placebo + azacitidine in patients with newly diagnosed acute myeloid leukemia with an IDH1 mutation. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2021-147805
NLM
Montesinos P, Recher C, Vives S, Zarzycka E, Wang J, Bertani G, Heuser M, Calado RT, Schuh AC, Yeh S-P, Daigle SR, Hui J, Zhang V, Pandya SS, Gianolio D, Botton S de, Döhner H. AGILE: a global, randomized, double-blind, phase 3 study of ivosidenib + azacitidine versus placebo + azacitidine in patients with newly diagnosed acute myeloid leukemia with an IDH1 mutation [Internet]. Blood. 2021 ; 138 697-697.[citado 2026 jan. 25 ] Available from: https://doi.org/10.1182/blood-2021-147805
Vancouver
Montesinos P, Recher C, Vives S, Zarzycka E, Wang J, Bertani G, Heuser M, Calado RT, Schuh AC, Yeh S-P, Daigle SR, Hui J, Zhang V, Pandya SS, Gianolio D, Botton S de, Döhner H. AGILE: a global, randomized, double-blind, phase 3 study of ivosidenib + azacitidine versus placebo + azacitidine in patients with newly diagnosed acute myeloid leukemia with an IDH1 mutation [Internet]. Blood. 2021 ; 138 697-697.[citado 2026 jan. 25 ] Available from: https://doi.org/10.1182/blood-2021-147805
Trabalho de evento-resumo periodico
Immunogenetic, molecular and clinical determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria (2021)
Gurnari, Carmelo; Pagliuca, Simona; Prata, Pedro Henrique de Lima; Catto, Luiz Fernando Bazzo ; Larcher, Lise; Sebert, Marie; Allain, Vincent; Patel, Bhumika J.; Terkawi, Laila; Santos, André Luiz Pinto ; Inacio, Mariana Carolina Beraldo; Hernandez, Lucie; Dhedin, Nathalie; Caillat-Zucman, Sophie; Clappier, Emmanuelle; Fontbrune, Flore Sicre de; Voso, Maria Teresa; Visconte, Valeria; Socie, Gerard; Calado, Rodrigo Tocantins ; Peffault de Latour, Regis; Soulier, Jean; Maciejewski, Jaroslaw P.
Source: Blood. Conference titles: ASH Annual Meeting Abstracts. Unidade: FMRP
Subjects: ANEMIA, CONTAGEM DE CÉLULAS SANGUÍNEAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GURNARI, Carmelo et al. Immunogenetic, molecular and clinical determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-147556. Acesso em: 25 jan. 2026. , 2021
APA
Gurnari, C., Pagliuca, S., Prata, P. H. de L., Catto, L. F. B., Larcher, L., Sebert, M., et al. (2021). Immunogenetic, molecular and clinical determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2021-147556
NLM
Gurnari C, Pagliuca S, Prata PH de L, Catto LFB, Larcher L, Sebert M, Allain V, Patel BJ, Terkawi L, Santos ALP, Inacio MCB, Hernandez L, Dhedin N, Caillat-Zucman S, Clappier E, Fontbrune FS de, Voso MT, Visconte V, Socie G, Calado RT, Peffault de Latour R, Soulier J, Maciejewski JP. Immunogenetic, molecular and clinical determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria [Internet]. Blood. 2021 ; 138 602-602.[citado 2026 jan. 25 ] Available from: https://doi.org/10.1182/blood-2021-147556
Vancouver
Gurnari C, Pagliuca S, Prata PH de L, Catto LFB, Larcher L, Sebert M, Allain V, Patel BJ, Terkawi L, Santos ALP, Inacio MCB, Hernandez L, Dhedin N, Caillat-Zucman S, Clappier E, Fontbrune FS de, Voso MT, Visconte V, Socie G, Calado RT, Peffault de Latour R, Soulier J, Maciejewski JP. Immunogenetic, molecular and clinical determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria [Internet]. Blood. 2021 ; 138 602-602.[citado 2026 jan. 25 ] Available from: https://doi.org/10.1182/blood-2021-147556

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Non normalized affiliation

Countries of institutions of collaboration